Supernus Pharmaceuticals Inc (SUPN) — Net Asset Quality Index
Supernus Pharmaceuticals Inc (SUPN) has a Net Asset Quality Index of 72.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.43 Billion minus total liabilities of $396.88 Million yields net assets of $1.03 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Supernus Pharmaceuticals Inc carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Supernus Pharmaceuticals Inc Net Asset Quality Index Over Time (2008–2025)
This chart shows how Supernus Pharmaceuticals Inc's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 72.2%, representing net assets of $1.03 Billion against total assets of $1.43 Billion USD. For live market cap and overall valuation, see market value of Supernus Pharmaceuticals Inc.
Annual Net Asset Quality Index for Supernus Pharmaceuticals Inc (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Supernus Pharmaceuticals Inc from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Supernus Pharmaceuticals Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.1% | $1.06 Billion | $1.45 Billion | $390.93 Million | ▼ -2.6 pp |
| 2024 | 75.7% | $1.04 Billion | $1.37 Billion | $332.34 Million | ▲ +3.6 pp |
| 2023 | 72.1% | $921.52 Million | $1.28 Billion | $356.16 Million | ▲ +20.1 pp |
| 2022 | 52.1% | $886.20 Million | $1.70 Billion | $816.30 Million | ▲ +3.8 pp |
| 2021 | 48.3% | $815.85 Million | $1.69 Billion | $873.30 Million | ▼ -1.2 pp |
| 2020 | 49.5% | $744.86 Million | $1.50 Billion | $759.24 Million | ▼ -1.8 pp |
| 2019 | 51.3% | $595.43 Million | $1.16 Billion | $564.85 Million | ▲ +5.0 pp |
| 2018 | 46.3% | $453.02 Million | $977.81 Million | $524.79 Million | ▼ -16.7 pp |
| 2017 | 63.0% | $267.48 Million | $424.46 Million | $156.98 Million | ▲ +1.1 pp |
| 2016 | 61.9% | $191.75 Million | $309.57 Million | $117.81 Million | ▼ -1.0 pp |
| 2015 | 63.0% | $118.88 Million | $188.73 Million | $69.86 Million | ▲ +11.1 pp |
| 2014 | 51.9% | $71.35 Million | $137.51 Million | $66.15 Million | ▲ +21.7 pp |
| 2013 | 30.1% | $33.46 Million | $111.00 Million | $77.53 Million | ▼ -31.1 pp |
| 2012 | 61.3% | $57.57 Million | $93.99 Million | $36.42 Million | ▲ +43.7 pp |
| 2011 | 17.6% | $9.44 Million | $53.73 Million | $44.29 Million | ▲ +111.9 pp |
| 2010 | -94.3% | $-44.32 Million | $47.01 Million | $91.33 Million | ▼ -86.6 pp |
| 2009 | -7.7% | $-6.16 Million | $79.90 Million | $86.06 Million | ▲ +1.0 pp |
| 2008 | -8.7% | $-6.75 Million | $77.13 Million | $83.88 Million | — |